THE ENDOCANNABINOID SYSTEM PROVIDES AN AVENUE FOR EVIDENCE-BASED TREATMENT DEVELOPMENT FOR PTSD

Authors


Correspondence to: Alexander Neumeister, M.D., Professor of Psychiatry and Radiology, New York University School of Medicine, Director, Molecular Imaging Program for Anxiety & Mood Disorders, One Park Avenue, 8th floor, room 225, New York, NY 10016. E-mail: alexander.neumeister@nyumc.org

Ancillary